Novo Nordisk's Wegovy pill sales beat forecasts amid rivalry with Lilly

Novo Nordisk reported Wegovy pill sales of kr5.39 billion, up 53% from Q2 and above the kr4.62 billion company-compiled consensus forecast. The item does not detail the Lilly competition.

Timeline

1. 4 Nov, 07:43 UTCFree Malaysia Today reports Wegovy pill beats forecasts

Top sources

• Novo Nordisk’s Wegovy pill beats forecasts as it battles LillyFree Malaysia Today